Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

652 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
What's New in Grade II and Grade III Gliomas?
Miller JJ, Wick W. Miller JJ, et al. Semin Neurol. 2018 Feb;38(1):41-49. doi: 10.1055/s-0037-1620275. Epub 2018 Mar 16. Semin Neurol. 2018. PMID: 29548051 Review.
Accelerated progression of IDH mutant glioma after first recurrence.
Miller JJ, Loebel F, Juratli TA, Tummala SS, Williams EA, Batchelor TT, Arrillaga-Romany I, Cahill DP. Miller JJ, et al. Neuro Oncol. 2019 May 6;21(5):669-677. doi: 10.1093/neuonc/noz016. Neuro Oncol. 2019. PMID: 30668823 Free PMC article.
Lower Grade Gliomas.
Youssef G, Miller JJ. Youssef G, et al. Among authors: miller jj. Curr Neurol Neurosci Rep. 2020 May 22;20(7):21. doi: 10.1007/s11910-020-01040-8. Curr Neurol Neurosci Rep. 2020. PMID: 32444979 Free PMC article. Review.
Targeting IDH-Mutant Glioma.
Miller JJ. Miller JJ. Neurotherapeutics. 2022 Oct;19(6):1724-1732. doi: 10.1007/s13311-022-01238-3. Epub 2022 Apr 27. Neurotherapeutics. 2022. PMID: 35476295 Free PMC article. Review.
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.
Miller JJ, Gonzalez Castro LN, McBrayer S, Weller M, Cloughesy T, Portnow J, Andronesi O, Barnholtz-Sloan JS, Baumert BG, Berger MS, Bi WL, Bindra R, Cahill DP, Chang SM, Costello JF, Horbinski C, Huang RY, Jenkins RB, Ligon KL, Mellinghoff IK, Nabors LB, Platten M, Reardon DA, Shi DD, Schiff D, Wick W, Yan H, von Deimling A, van den Bent M, Kaelin WG, Wen PY. Miller JJ, et al. Neuro Oncol. 2023 Jan 5;25(1):4-25. doi: 10.1093/neuonc/noac207. Neuro Oncol. 2023. PMID: 36239925 Free PMC article.
IDH-mutant glioma: A new IDH1 inhibitor moves forward.
Miller JJ, Arrillaga-Romany I. Miller JJ, et al. Neuro Oncol. 2023 Feb 14;25(2):337-338. doi: 10.1093/neuonc/noac275. Neuro Oncol. 2023. PMID: 36526609 Free PMC article. No abstract available.
652 results